Mkk3/p38 MAPK, Macrophage Apoptosis, and Atherosclerosis
Mkk3/p38 MAPK、巨噬细胞凋亡和动脉粥样硬化
基本信息
- 批准号:7242637
- 负责人:
- 金额:$ 0.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-06-07 至 2007-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAffectApolipoprotein EApoptosisApoptoticArterial Fatty StreakAtherosclerosisBenignBlood VesselsCalciumCessation of lifeCholesterolCholesterol EstersCoagulantsDataDevelopmentDiseaseDistalEndopeptidasesEndoplasmic ReticulumGenerationsGoalsInflammatoryLaboratoriesLesionLesion by MorphologyLipoproteinsMAP Kinase GeneMAPK14 geneMitochondriaMolecularMorphologyMusNecrosisPathway interactionsPeptide HydrolasesPeritoneal MacrophagesPhosphotransferasesPlayPreventionProteinsRoleSchemeSignal PathwaySignal TransductionSignal Transduction PathwayStagingThinkingWild Type MouseWorkatherogenesisbasecholesterol traffickingin vivoin vivo Modelinsightmacrophageresponse
项目摘要
DESCRIPTION (provided by applicant): Macrophages are found in advanced atherosclerotic plaques, and have been shown to have an increased abundance of free cholesterol (FC) accumulation. FC is a potent inducer of macrophage apoptosis. Aim I will elucidate the role of the MKK3/p38 MAPK pathway in induction of the Unfolded Protein Response (UPR), and distal apoptotic pathways in FC-loaded macrophages. Peritoneal macrophages from wild-type mice, or mice deficient in MKK3 and p38alpha, will be used to ask if this signaling pathway is upstream of cholesterol trafficking to the endoplasmic reticulum (ER), or depletion of ER Ca2+ stores in response to FC loading. Aim II will determine the role of the MKK3/p38 MAPK pathway in atherosclerotic lesion progression using an in-vivo model of atherogenesis. Mkk3-/- and p38alpha-floxed/LysMCre mice crossed onto an Apoe-/- background will be used to determine if blocking the MKK3/p38 MAPK pathway results in inhibition of macrophage apoptosis in-vivo, and alters atherosclerotic lesion morphology. The main objective of this proposal is to elucidate the molecular mechanisms connecting the MKK3/p38 MAPK pathway, induction of the UPR, and determine if this pathway influences macrophage apoptosis and atherosclerosis in-vivo.
描述(由申请人提供):在晚期动脉粥样硬化斑块中发现巨噬细胞,并且已显示其具有增加的游离胆固醇(FC)积累丰度。FC是一种强有力的巨噬细胞凋亡诱导剂。目的阐明MKK 3/p38 MAPK通路在FC负载的巨噬细胞诱导未折叠蛋白反应(UPR)和远端凋亡通路中的作用。来自野生型小鼠或MKK 3和p38 α缺陷小鼠的腹膜巨噬细胞将用于询问该信号传导途径是否是胆固醇运输至内质网(ER)的上游,或响应于FC负荷的ER Ca 2+储存的消耗。目的II将使用动脉粥样硬化形成的体内模型确定MKK 3/p38 MAPK通路在动脉粥样硬化病变进展中的作用。将使用与Apoe-/-背景杂交的Mkk 3-/-和p38 α-floxed/LysMCre小鼠来确定阻断MKK 3/p38 MAPK通路是否导致体内巨噬细胞凋亡的抑制,并改变动脉粥样硬化病变形态。本提案的主要目的是阐明连接MKK 3/p38 MAPK通路、诱导UPR的分子机制,并确定该通路是否影响体内巨噬细胞凋亡和动脉粥样硬化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TRACIE Alexis SEIMON其他文献
TRACIE Alexis SEIMON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TRACIE Alexis SEIMON', 18)}}的其他基金
Mkk3/p38 MAPK, Macrophage Apoptosis, and Atherosclerosis
Mkk3/p38 MAPK、巨噬细胞凋亡和动脉粥样硬化
- 批准号:
6885044 - 财政年份:2005
- 资助金额:
$ 0.86万 - 项目类别:
Mkk3/p38 MAPK, Macrophage Apoptosis, and Atherosclerosis
Mkk3/p38 MAPK、巨噬细胞凋亡和动脉粥样硬化
- 批准号:
7061619 - 财政年份:2005
- 资助金额:
$ 0.86万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 0.86万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 0.86万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 0.86万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 0.86万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 0.86万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 0.86万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 0.86万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 0.86万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 0.86万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 0.86万 - 项目类别:
Research Grant